Analysts’ Price Target Changes for April 21st (ABDN, ABT, ADP, AEE, AEP, AFRM, AGIO, ALB, AMZN, ANF)
Analysts’ price target changes for Tuesday, April 21st: abrdn (LON:ABDN) had its target price cut by JPMorgan Chase & Co. from GBX 242 to GBX 234. They currently have an overweight rating on the stock. Abbott Laboratories (NYSE:ABT) had its price target reduced by Leerink Partners from $119.00 to $106.00. The firm currently has a [...]